Botulinum toxin

JDD March 2024 Issue Highlights
213712137121371alopeciaMarch into groundbreaking dermatological insights with the latest issue of the Journal of Drugs in Dermatology! Explore the prescribing habits of oral minoxidil for androgenetic alopecia, delve into a comprehensive review of botulinum toxin uses, and discover the effectiveness of microneedling for acne scars. Plus, unravel the uncertainties surrounding exosome therapy in androgenetic alopecia. Fro …
alopecia
JDD January 2024 Issue Highlights
204802048020480Journal of Drugs in DermatologyThe Journal of Drugs in Dermatology welcomes 2024 with a strong line up of original articles, case reports, brief communications, and letters to the editor. Straight from the Editor's desk, we share this month's issue highlights! ORIGINAL ARTICLES Current Landscape of Hyaluronic Acid Filler Use in the United States shares the results of a comprehensive search of all the FDA approved dermal fill …
Journal of Drugs in Dermatology
Placement of High Dose Neurotoxins for Treatment-Resistant Rosacea
180071800718007rosaceaRosacea is a chronic inflammatory skin condition characterized by facial flushing, erythema, telangiectasias, and papulopustular lesions. Treatment for rosacea includes limiting inciting factors and reducing inflammation with topical and oral therapies. Traditional therapies primarily focus on the papulopustular or background erythematotelangiectatic component of rosacea, leaving symptoms of flush …
rosacea
Journal Buzz: Botulinum Toxin for Hidradenitis Suppurativa | The Expert Weighs In
161391613916139botulinum toxinBotulinum toxin is a safe and potentially effective treatment alternative in hidradenitis suppurativa (HS) patients who are resistant to standard therapies, according to the authors of a systematic review published in the Journal of Drugs in Dermatology. How does this review add to the conversation about new treatments for HS? In which HS patients might dermatologists consider botulinum toxin as …
botulinum toxin
JDD Issue Highlights | April 2022
153551535515355psoriasisThe April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
psoriasis